Last reviewed · How we verify

NCT07306091

Decanulation in Critically Ill Patients

ENROLLING BY INVITATION Last updated 29 December 2025
What this trial tests

trial testing ultrasound guided airway examination in Decanulation in 107 participants. Enrolling by invitation.

Timeline
1 July 2024
Primary endpoint
31 December 2025
1 February 2026

Quick facts

Lead sponsorUludag University
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment107
Start date1 July 2024
Primary completion31 December 2025
Estimated completion1 February 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Uludag University

Who can join

18 and older, any sex, with Decanulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose of the Study: To predict potential problems (such as shortness of breath and obstruction of the airway due to vocal cord immobility) before the tracheostomy cannula is removed, the patient's vocal cords, their movement, and airflow rate will be assessed at the bedside. The patient will also be examined using routine methods to identify these problems, and the results will be compared with ultrasound scans. The study aims to determine the success and failure of ultrasound in detecting these problems. Method and Procedures: While the patient is receiving treatment in the intensive care unit, the probe of the existing ultrasound device will be placed on the patient's neck, over the cannula, and the movement of the vocal cords and airflow rate will be assessed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Uludag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07306091.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing